50 results on '"Yang, Hongbo"'
Search Results
2. Association Between Patient and System Delays and In-Hospital Mortality in Primary PCI for STEMI: Findings from a Large, Nationwide Inpatients Sample
3. Importance of cold rolling and tempering on the microstructure evolution, precipitation behavior and mechanical responses of 9Cr3Co3W1Cu ferritic/martensitic steel
4. Serum metabolomics profiling of improved metabolic syndrome is characterized by decreased pro-inflammatory biomarkers: A longitudinal study in Chinese male adults
5. Evaluating the use of pharmacological stress agents during single-photon emission computed tomography myocardial perfusion imaging tests after inadequate exercise stress test
6. Indirect comparison of tisagenlecleucel and historical treatments for relapsed/refractory diffuse large B-cell lymphoma
7. Indirect comparison of tisagenlecleucel and blinatumomab in pediatric relapsed/refractory acute lymphoblastic leukemia
8. Hemophilia Gene Therapy Value Assessment: Methodological Challenges and Recommendations
9. Factors that impact a patient’s experience when undergoing single-photon emission computed tomography myocardial perfusion imaging (SPECT-MPI) in the US: A survey of patients, imaging center staff, and physicians
10. Cost-Effectiveness Analysis of Tisagenlecleucel for the Treatment of Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma in the United States
11. Risk of Thromboembolic Events and Associated Risk Factors, Including Treatments, in Patients with Immune-mediated Diseases
12. Health care resource utilization and cost burden of hemophilia B in the United States
13. Growth-Promoting Therapies May Be Useful In Short Stature Patients With Nonspecific Skeletal Abnormalities Caused By Acan Heterozygous Mutations: Six Chinese Cases And Literature Review
14. The Development of Health Technology Assessment in Asia: Current Status and Future Trends
15. Platelet membrane-coated nanoparticle-mediated targeting delivery of Rapamycin blocks atherosclerotic plaque development and stabilizes plaque in apolipoprotein E-deficient (ApoE−/−) mice
16. Clinical Outcomes Associated with Switching or Discontinuation from Anti-TNF Inhibitors for Nonmedical Reasons
17. Cost Effectiveness Analysis of Tisagenlecleucel for the Treatment of Adult Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma in Japan
18. Cost-Effectiveness Analysis of Tisagenlecleucel for the Treatment of Pediatric and Young Adult Patients with Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia in Japan
19. Developing a Risk Score to Guide Individualized Treatment Selection in Attention Deficit/Hyperactivity Disorder
20. The direct and indirect costs of uterine fibroid tumors: a systematic review of the literature between 2000 and 2013
21. Double Kissing Inflation Outside the Stent Versus Jailed Balloon Technique for Coronary Bifurcation Lesions
22. CML-619 Adverse Events (AEs) Among Patients With Chronic Myeloid Leukemia (CML) Receiving Tyrosine Kinase Inhibitors and Subsequent Treatment Adjustment: A Large US Commercial Claims Database Analysis
23. Adverse Events (AEs) Among Patients With Chronic Myeloid Leukemia (CML) Receiving Tyrosine Kinase Inhibitors and Subsequent Treatment Adjustment: A Large US Commercial Claims Database Analysis
24. Retraction notice to “Aberrant expression of lncRNA MALAT1 modulates radioresistance in colorectal cancer in vitro via miR-101-3p sponging” [Experimental and Molecular Pathology 115 (2020) 104448].
25. RETRACTED: Aberrant expression of lncRNA MALAT1 modulates radioresistance in colorectal cancer in vitro via miR-101-3p sponging
26. 252 - Matching-Adjusted Indirect Comparison of Efficacy and Safety for Tisagenlecleucel and Mosunetuzumab in Patients (pts) with Relapsed/Refractory Follicular Lymphoma (r/r FL)
27. 77 - Comparative Efficacy and Safety of Tisagenlecleucel (tisa-cel) and Axicabtagene Ciloleucel (axi-cel) in Relapsed/ Refractory Follicular Lymphoma (r/r FL)
28. Patient and Physician Preferences for Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) in Patients Not Candidates for Intensive Chemotherapy
29. TCT-484 Double Kissing Inflation Outside the Stent for Coronary Bifurcated Lesions With Small Side Branch
30. 25572 Impact of risankizumab on the duration of PASI90 achievement: A post hoc analysis of 4 phase III clinical trials
31. 25574 The impact of PASI90 duration on patient reported outcomes among patients with psoriasis
32. Fr550 THE ECONOMIC BURDEN OF THROMBOEMBOLIC EVENTS AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE
33. A ST-Segment Elevation Myocardial Infarction Mimic in a Young Male
34. Letter to the Editor Regarding “Comparing Efficacy, Safety, and Preinfusion Period of Axicabtagene Ciloleucel versus Tisagenlecleucel in Relapsed/Refractory Large B Cell Lymphoma”
35. Patient Preferences for Hemophilia a Treatments: A Discrete Choice Experiment
36. Cost-Effectiveness Analysis of Gilteritinib Versus Best Supportive Care (BSC) for the Treatment of Relapsed or Refractory (R/R) FLT3 Mutation-Positive (FLT3mut+) Acute Myeloid Leukemia (AML)
37. Estimation of Total Costs in Pediatric and Young Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia Receiving Tisagenlecleucel from a US Hospital's Perspective
38. Cost-Effectiveness Analysis of Gilteritinib Versus Salvage Chemotherapy (SC) for the Treatment of Relapsed or Refractory (R/R) FLT3-Mutated (FLT3mut+) Acute Myeloid Leukemia (AML)
39. Estimation of Total Costs in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Receiving Tisagenlecleucel from a US Hospital's Perspective
40. A longitudinal assessment of the impact of endometriosis on patients’ salaries
41. Treatment Patterns and Healthcare Resource Utilization (HRU) in Patients with Relapsed/Refractory (R/R) FLT3-Mutated (FLT3mut) and FLT3-Wild Type (FLT3wt) Acute Myeloid Leukemia (AML): A Multi-Country Medical Chart Study
42. Restenosis in Magmaris Stents Due to Significant Collapse
43. Treatment Patterns and Healthcare Resource Utilization in Patients with FLT3-Mut and FLT3-Wt Acute Myeloid Leukemia: A Multi-Country Medical Chart Study
44. Cost-Effectiveness Analysis of CTL019 for the Treatment of Pediatric and Young Adult Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia in the United States
45. Characterization of Causal Variants at the GATA3 Loci Associated with Susceptibility to Ph-like Acute Lymphoblastic Leukemia
46. Costs per Month Free of Progression or Death of Targeted Therapies in the Treatment of Relapsed/Refractory Multiple Myeloma
47. Economic Consequences of Cytomegalovirus Disease Among Stem Cell Transplant Recipients
48. Diffuse ST-Segment Elevation in Myocardial Infarction
49. Intramyocardial contrast in a STEMI patient early direct evidence of cardiac rupture
50. Severe bilateral cataracts and intracranial calcifications in chronic hypoparathyroidism
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.